Calquence for Mantle Cell Lymphoma User Reviews
- Che...
- Taken for 1 to 6 months
- August 30, 2023
"So far, no major issues. I have been using it for about 4 months now, since Imbruvica was pulled for mantle cell lymphoma treatment. Bowels move a bit differently than with Imbruvica, but not enough so as to be a problem. My doctors seem to be well satisfied with the way it is working, holding the lymphoma in check if nothing else."
- sd ...
- Taken for 6 months to 1 year
- December 13, 2024
"Have severe brain fog, could not live with, had to change to zanabrutinib."
Frequently asked questions
- Nan...
- Taken for 1 to 6 months
- May 14, 2024
"Minor side effects very manageable. I highly recommend trying Calquence!"
See also:
Rituxan
Rituxan infusion is used to treat certain leukemias and lymphomas and some non-cancer conditions ...
Kesimpta
Kesimpta is used to treat relapsing forms of multiple sclerosis (MS), including clinically isolated ...
Imbruvica
Imbruvica (ibrutinib) is used to treat chronic lymphocytic leukemia (CLL), small lymphocytic ...
Brukinsa
Brukinsa is used to treat adults with mantle cell lymphoma, Waldenström’s macroglobulinemia, ma ...
Venclexta
Venclexta may be used to treat chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma ...
Zanubrutinib
Zanubrutinib is a targeted treatment that may be used to treat adults with chronic lymphocytic ...
Ibrutinib
Ibrutinib (Imbruvica) is a Bruton's tyrosine kinase inhibitor used for certain blood cancers and ...
Venetoclax
Venetoclax (brand name Venclexta) may be used to treat CLL, SLL, or AML in those aged 75 years or ...
Cyclophosphamide
Cyclophosphamide is used for acute lymphocytic leukemia, acute nonlymphocytic leukemia, brain ...
Are you taking this medicine?
Your review helps others make informed decisions.More about Calquence (acalabrutinib)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (34)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: BTK inhibitors
- Breastfeeding
- En español
"My latest PET scan showed that Calquence is working to reduce MCL activity. Side effects mostly occurred when I started the medication, and they were brief. These included fatigue, tinnitus in my left ear, lower appetite, and weight loss. My weight is now stable, although down about 13 pounds from when I started. But I’m okay with that, since it’s a better weight for me. I do have some rashes, which my oncologist says are due to the medication."